[go: up one dir, main page]

AR102008A1 - ACTIVE PHARMACEUTICAL INGREDIENT (IFA) OLEOUS FOR THE TREATMENT OF SKIN AFFECTIONS, COMPOSITIONS THAT INCLUDE IT AND ITS USE TO PREPARE THEM - Google Patents

ACTIVE PHARMACEUTICAL INGREDIENT (IFA) OLEOUS FOR THE TREATMENT OF SKIN AFFECTIONS, COMPOSITIONS THAT INCLUDE IT AND ITS USE TO PREPARE THEM

Info

Publication number
AR102008A1
AR102008A1 ARP150103064A ARP150103064A AR102008A1 AR 102008 A1 AR102008 A1 AR 102008A1 AR P150103064 A ARP150103064 A AR P150103064A AR P150103064 A ARP150103064 A AR P150103064A AR 102008 A1 AR102008 A1 AR 102008A1
Authority
AR
Argentina
Prior art keywords
composition
acid
ifa
prepare
treatment
Prior art date
Application number
ARP150103064A
Other languages
Spanish (es)
Inventor
Ramn Acosta Felipe
Dobboletta Mauricio
Original Assignee
Brix S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brix S R L filed Critical Brix S R L
Priority to ARP150103064A priority Critical patent/AR102008A1/en
Priority to ES201890018A priority patent/ES2672314B1/en
Priority to BR112018005922A priority patent/BR112018005922A2/en
Priority to PCT/US2015/067503 priority patent/WO2017052678A1/en
Publication of AR102008A1 publication Critical patent/AR102008A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)

Abstract

Ingrediente farmacéutico activo (IFA) oleoso para el tratamiento de afecciones de la piel, que comprende: ácido oleico de aproximadamente 35 a aproximadamente 55 g, ácido palmítico de aproximadamente 15 a aproximadamente 32 g, ácido linoleico de aproximadamente 10 a aproximadamente 20 g, ácido esteárico de aproximadamente 7,5 a aproximadamente 9 g, ácido linolénico de aproximadamente 0,5 a aproximadamente 1,5 g, vitamina A (como palmitato) 1,7 MUI/g de aproximadamente 0,8 a aproximadamente 1,2 g, y vitamina E (como acetato) de aproximadamente 0,1 a aproximadamente 0,24 g. Composición de crema regeneradora de epidermis, composición de crema cicatrizante epidérmica, composición de crema nutritiva epitelial, composición de gel cicatrizante en aerosol, composición líquida nasal para tratar rinitis alérgica, composición en crema para tratar psoriasis y composición de jabón líquido que lo comprenden. Uso del mismo para prepararlas.Oily active pharmaceutical ingredient (IFA) for the treatment of skin conditions, comprising: oleic acid from about 35 to about 55 g, palmitic acid from about 15 to about 32 g, linoleic acid from about 10 to about 20 g, acid stearic acid from about 7.5 to about 9 g, linolenic acid from about 0.5 to about 1.5 g, vitamin A (as palmitate) 1.7 MUI / g from about 0.8 to about 1.2 g, and Vitamin E (as acetate) from about 0.1 to about 0.24 g. Composition of epidermis regenerating cream, epidermal healing cream composition, epithelial nourishing cream composition, aerosol healing gel composition, nasal liquid composition for treating allergic rhinitis, cream composition for treating psoriasis and liquid soap composition comprising it. Use of it to prepare them.

ARP150103064A 2015-09-24 2015-09-24 ACTIVE PHARMACEUTICAL INGREDIENT (IFA) OLEOUS FOR THE TREATMENT OF SKIN AFFECTIONS, COMPOSITIONS THAT INCLUDE IT AND ITS USE TO PREPARE THEM AR102008A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ARP150103064A AR102008A1 (en) 2015-09-24 2015-09-24 ACTIVE PHARMACEUTICAL INGREDIENT (IFA) OLEOUS FOR THE TREATMENT OF SKIN AFFECTIONS, COMPOSITIONS THAT INCLUDE IT AND ITS USE TO PREPARE THEM
ES201890018A ES2672314B1 (en) 2015-09-24 2015-12-22 Oily active pharmaceutical ingredient (IFA) for the treatment of skin conditions, compositions that comprise it and its use to prepare them
BR112018005922A BR112018005922A2 (en) 2015-09-24 2015-12-22 active pharmaceutical ingredient and its use, epidermal regenerating cream and epidermal healing composition, epithelial and nourishing cream composition, aerosol healing gel composition, nasal liquid composition and liquid soap composition
PCT/US2015/067503 WO2017052678A1 (en) 2015-09-24 2015-12-22 Oily active pharmaceutical ingredient (api) for the treatment of skin conditions, compositions comprising same, and use thereof for preparing said compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP150103064A AR102008A1 (en) 2015-09-24 2015-09-24 ACTIVE PHARMACEUTICAL INGREDIENT (IFA) OLEOUS FOR THE TREATMENT OF SKIN AFFECTIONS, COMPOSITIONS THAT INCLUDE IT AND ITS USE TO PREPARE THEM

Publications (1)

Publication Number Publication Date
AR102008A1 true AR102008A1 (en) 2017-01-25

Family

ID=58387046

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150103064A AR102008A1 (en) 2015-09-24 2015-09-24 ACTIVE PHARMACEUTICAL INGREDIENT (IFA) OLEOUS FOR THE TREATMENT OF SKIN AFFECTIONS, COMPOSITIONS THAT INCLUDE IT AND ITS USE TO PREPARE THEM

Country Status (4)

Country Link
AR (1) AR102008A1 (en)
BR (1) BR112018005922A2 (en)
ES (1) ES2672314B1 (en)
WO (1) WO2017052678A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR112188A1 (en) * 2018-05-22 2019-10-02 Brix S R L ORAL COMPOSITION OF CITRUS PECTIN AND PAPAIN, METHODS TO PREPARE IT IN SOFT CAPSULE AND SYRUP DOSAGE FORMS
RU2712636C1 (en) * 2019-06-26 2020-01-30 Андрей Иванович Полилов Cosmetic homeopathic preparation for regenerating scar tissue of skin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103246A (en) * 1993-06-03 2000-08-15 Tisdale; Carrie J. Creams and lotions containing emu oil
US5444092A (en) * 1994-07-20 1995-08-22 Collins; Jerry Method and composition for treating psoriasis
AU1944599A (en) * 1997-12-24 1999-07-19 Shaklee Corporation Composition with high efficiency skin protection from damaging effects of ultraviolet light
BRPI0904577A2 (en) * 2009-06-22 2011-03-01 Pharma Nostra Com Ltda process for preparing cosmetic composition with high absorption pharmaceutical properties, cosmetic composition with high absorption pharmaceutical properties; method for the prevention and / or treatment of mammalian skin inflammation using cosmetic composition with high absorption pharmaceutical properties, method for regenerating radiotherapy cutaneous tissue using cosmetic composition with high absorption pharmaceutical properties
US20120252888A1 (en) * 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
US9138446B2 (en) * 2011-06-08 2015-09-22 Scott Alan Weisenfluh EMU oil in combination with other active ingredients for treating skin imperfections
ITMI20111284A1 (en) * 2011-07-11 2013-01-12 Giovanni Nusca PHARMACEUTICAL COMPOSITION.
ITMI20130354A1 (en) * 2013-03-08 2014-09-09 Again Life Italia Srl MIXTURE OF FATTY ACIDS (F.A.G. FATTY ACIDS GROUP) FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES.
WO2014165253A1 (en) * 2013-03-12 2014-10-09 Nbip, Llc Compositions and methods for preventing infection of a wound and for advancing the healing process
BR102013022835A2 (en) * 2013-09-03 2015-08-11 Fundação Universidade Fed De Mato Grosso Do Sul Cosmetic and / or pharmaceutical composition to promote cell regeneration and stimulate angiogenesis

Also Published As

Publication number Publication date
WO2017052678A1 (en) 2017-03-30
ES2672314B1 (en) 2019-12-11
ES2672314A2 (en) 2018-06-13
ES2672314R1 (en) 2018-11-21
BR112018005922A2 (en) 2018-10-09

Similar Documents

Publication Publication Date Title
MX2017006113A (en) Novel polymeric hgh prodrugs.
MX2016007067A (en) Lipid microcapsules preferably comprising a retinoid, and composition containing same, method for the production thereof, and use thereof in dermatology.
EA201691808A8 (en) CORTICOSTEROID COMPOSITIONS FOR LOCAL APPLICATION
MX367091B (en) TOPICAL COMPOSITIONS and METHODS OF USE.
BR112012015433B8 (en) substantially anhydrous pharmaceutical composition for cutaneous application
FR3024037B1 (en) COSMETIC OR DERMATOLOGICAL ACTIVE INGREDIENT COMPRISING A MIXTURE OF UNSATURATED FATTY DICARBOXYLIC ACIDS, COMPOSITIONS COMPRISING THE SAME, AND COSMETIC OR DERMATOLOGICAL USES
CL2015000039A1 (en) Estra-1,3,5 (10), 16-tetraeno-3-substituted derivatives, pharmaceutical preparations that comprise them and their use in the preparation of medicaments for treating endometriosis.
MX2018000262A (en) Therapeutic uses of berberine formulations.
MY191980A (en) Formulations containing an extract of echinacea and linoleic acid derivatives
WO2015081904A3 (en) Polyurethaneurea solutions for compositions with active ingredients or fragrances
AR108935A1 (en) AQUENIO EXTRACT OF SILYBUM MARIANUM AND ITS USES IN DERMATOLOGY AND DERMOCOSMÉTICA
PH12018500910A1 (en) Novel method of use and compositions
MX379253B (en) STABILIZED OXYMETAZOLINE FORMULATIONS AND THEIR USES.
BR112013011064A2 (en) nutraceutical or oral cosmetic use and oral cosmetic treatment process
AR102008A1 (en) ACTIVE PHARMACEUTICAL INGREDIENT (IFA) OLEOUS FOR THE TREATMENT OF SKIN AFFECTIONS, COMPOSITIONS THAT INCLUDE IT AND ITS USE TO PREPARE THEM
MA51278A (en) USE OF A PLANT EXTRACT AS AN ACTIVE AGENT IN THE TREATMENT OF DERMATOLOGICAL DISEASES
NZ705592A (en) Quick-penetrating soft skin-care cream
MX2019014426A (en) Pharmaceutical composition to be used for modification of scalp or skin, healing of wound or modification of hair.
CR20190007A (en) SOLID PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS THAT INCLUDE OILS.
MX2022013816A (en) Pharmaceutical composition to be used for increasing hair, modifying scalp or skin, healing wounds, promoting osteogenesis, or modifying hair.
BR112014032850A2 (en) combinations of active ingredients, cosmetic or dermatological preparations, and use of combinations of active ingredients
CL2018000753A1 (en) Vitamin E-based hydrophobic gel free of silicone products for topical application
MX382521B (en) NEW PROPYNYL BIOAROMATIC COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THE SAME AND USES THEREOF.
MX2017013265A (en) Compositions for long-lasting moisturizing cosmetic formulation comprising ucuuba butter with high concentration of myristic acid, as well as the use of said formulation for the preparation of a highly moisturizing cosmetic product and kit.
UY36130A (en) SILINATED IMINA AND CARBAMATE POLYMERIC BENZOATE COMPOUNDS, USES AND COMPOSITIONS OF THE SAME

Legal Events

Date Code Title Description
FB Suspension of granting procedure